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ABSTRACT 
 
The colonization and accumulation of Streptococcus mutans are influenced by various factors in the oral 
cavity, such as nutrition and hygiene conditions of the host, salivary components, cleaning power and 
salivary flow and characteristics related with microbial virulence factors. Among these virulence factors, the 
ability to synthesize glucan of adhesion, glucan-binding proteins, lactic acid and bacteriocins could modify 
the infection process and pathogenesis of this species in the dental biofilm. This review will describe the role 
of mutacins in transmission, colonization, and/or establishment of S. mutans, the major etiological agent of 
human dental caries. In addition, we will describe the method for detecting the production of these inhibitory 
substances in vitro (mutacin typing), classification and diversity of mutacins and the regulatory mechanisms 
related to its synthesis. 
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INTRODUCTION AND REVIEW 
 
The role of mutacins in transmission, colonization and/or 
establishment of S. mutans  
Most S. mutans strains produce mutacins (bacteriocins) 
that are antimicrobial peptides that can inhibit mainly the 
growth of bacteria genetically and environmentally related. 
Some mutacin-like substances present broad antimicrobial 
spectra and are able to inhibit the growth of indicator strains of 
medical interest that are resistant to some commonly used 
antibiotics, as well as Enterococcus faecalis, Streptococcus 
pyogenes, Staphylococcus aureus and Staphylococcus 
epidermidis, Escherichia coli and mycobacteria (28, 29, 41, 
49). 
The broad spectra of mutacins emphasize its importance in 
the future pharmacology applications, although more studies 
are necessary to acknowledge their use as a safe antimicrobial 
agent (41).      
The ability to produce mutacins by S. mutans may confer 
ecological advantages to producing strains on other sensitive 
bacteria in diverse bacterial communities such as dental biofilm 
and caries (4). The antagonism probably occurs at the tooth
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surface and may be important for the stability of S. mutans in 
situ. 
According to Grönroos et al. (16), mutacin production by 
S. mutans may promote transmission of bacteria from mother 
to child and may have significant role in the colonization 
process of this species in the oral cavity due to their selective 
antagonism mechanisms. Theoretically, the ability to produce 
broad spectrum mutacins could favor the colonization of 
producer S. mutans in the complex dental biofilm, thereby 
increasing the risk of caries (16). 
The mechanisms of mutacins in ecologic regulation of the 
oral microbiota are still unknown. For Rogers (52) the o role of 
mutcains in vivo is limited, because in the same niche in the 
oral cavity both producing and sensitive strains of S. mutans 
were isolated.  
Several in vitro studies with salivary enzymes (19) have 
not proven the enzymatic inactivation of mutacins. According 
to Parrot et al. (46) enzymatic inactivation of mutacins in the 
oral cavity is limited due to low concentrations of proteolytic 
substances in this environment. 
Saliva does not seem to affect the inhibitory activity of 
mutacins, because several in vivo studies have reported the 
most successful colonization of highly producing strains, in the 
oral cavity of rats and humans (25, 58). Some groups of 
researchers support the idea of using mutacins in the control 
and prevention of dental caries (22, 25). 
In 1985, Hillman et al. (23) observed the persistent 
colonization of the strain S. mutans JH1001, a producing strain 
of mutacin with high inhibitory spectra, in the oral cavity of 
humans, after four or more exposures to it. This experiment 
showed a positive correlation between the potential for 
infection in vivo and the levels of mutacin production in vitro. 
Based on the selective and ecological properties of mutacins in 
vivo, Hillman et al. (25) developed bacterial replacement 
therapy for preventing the development of dental caries in 
animals and humans. Basically, by constructing a mutant strain 
of S. mutans BCS3-L1, bacteriocin-producing with broad-
spectrum in vitro (mutacin 1140) and defective in the synthesis 
of lactic acid, it was possible to effect the colonization of the 
producing strain of low cariogenicity in oral cavity of rats and 
adult humans. The biological activity of mutacins in vivo 
reduced the rate of caries possibly due to inhibition of more 
cariogenic S. mutans competitors in the oral cavity, however, 
many experiments in humans still should be made so that the 
hypothesis of replacement therapy will be substantiated, as 
well as highly safe and effective in the prevention of dental 
caries (25).  
Although Mota Meira et al. (41) demonstrated, for the 
first time, the in vivo efficacy of a mutacin (B-Ny266) against 
an experimental intraperitoneal infection by S. aureus in a 
mouse model, the role of mutacins in vivo in the oral cavity is 
still unknown. The regulatory mechanisms involved in 
mutacins production, which will be described later in this 
review, suggest that producing strains can benefit in 
environments with highly complex microbial population, such 
as dental biofilm and caries. 
Another important feature that can show the activity of 
mutacins in the oral cavity is based on the adsorption capacity 
of active molecules of bacteriocins on the surface of sensitive 
bacteria through specific or not specific receptors (61). This 
characteristic of adsorption and aggregate formation can 
increase the antimicrobial efficiency of mutacins in situ while 
maintaining the active molecule in cells sensitive or not 
adhered to the dental biofilm. 
 
MUTACIN TYPING 
 
About 70-100% of S. mutans strains can produce mutacin-
like substances  (5, 6, 16, 26, 53) and different from the 
detected frequency of production, are probably due to the use 
of different indicator strains and differences in culture media 
and conditions for testing (53). 
The bacteriocin typing is based on the pattern of 
bacteriocins production against a set of strains, as well as the 
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sensitivity profile for different inhibitory substances (30, 53). 
This phenotypic method emerged in the 70s during the race in 
pursuit of global scientific epidemiological investigation of 
cariogenic streptococci and allowed grouping strains with 
similar profiles of production and / or sensitivity to 
bacteriocins, and made it possible to demonstrate the 
heterogeneity of species (30). According to Rogers (53), the 
high incidence of mutacin production in S. mutans promotes 
the use of phenotypic typing technique for this species. 
The bacteriocin typing of S. mutans is called mutacin 
typing and according to Arbeit (3), the technique possesses the 
basic criteria for typing of microorganisms as well as 
typeabiltiy (ability to classify the isolates), reproducibility 
(ability to obtain the same results in repeated analysis) and 
discrimination (ability to differentiate unrelated strains). From 
the late 80s on, molecular methods with higher discriminatory 
capacity improved the epidemiological studies and they have 
been commonly applied to study the genetic diversity of 
bacterial species from the oral cavity, replacing the methods for 
phenotypic analysis. 
After the discovery of the direct involvement of 
streptococci in the development of human dental caries (15, 
32), a global scientific race began in pursuit of elucidating the 
process of transmission and epidemiology of the major 
cariogenic microorganisms. 
Several scholars engaged in the discovery of possible 
routes of transmission of S. mutans, the primary etiologic agent 
of dental caries in order to control the disease. Early studies 
sought to classify S. mutans in sub-groups related antigenically 
(7). Using serotyping, Köhler & Bratthall (33) demonstrated 
that parents or guardians transmitted S. mutans to children, 
most of the time. The adults responsible for the transmission of 
bacteria through saliva and fomites, were carrying a large 
number of streptococci of a particular serotype in the saliva. In 
1980, Hamada et al. (20) proved that the same serotype could 
occur simultaneously in mother-child pairs (a) and that 
transmission could be propagated repeatedly by saliva. 
Currently, it is known that sub-groups may correspond 
antigenically related to different species. Davey & Rogers, in 
1984 (12), reported that the serotyping of mutans streptococci 
is unsatisfactory for epidemiological purposes, particularly 
since S. mutans serotype c is most frequently isolated in 
children and adults in the West. From the limitations of the 
classification of mutans streptococci by serotyping, several 
groups (5, 12, 54) began to use techniques with more 
discriminating infraspecific power like bacteriocin typing in 
the epidemiological investigation of mutans streptococci. 
Using this phenotypic method, Kelstrup et al. (30) 
demonstrated the heterogeneity and diversity of mutans 
streptococci in the same individual. Years later, Berkowitz & 
Jordan (5) found that the pattern of mutacins production 
analyzed in 120 S. mutans strains were similar between four 
mother-child pairs, suggesting a maternal transmission 
(vertical) of this species. In 1981, Rogers (54) reported that in 
88% of families analyzed in the study, two or more members, 
at least one represented by a parent, shared strains of S. mutans 
with the same phenotypic. 
A comparison of biotypes of S. mutans between different 
individuals led to the identification of mothers as the main 
source of infection of this species (5, 12), although not all 
maternal bacteriocintypes are transferred to their children (6).  
The composition of the culture medium can influence the 
sensitivity and the production of bacteriocins. Rogers (53), 
using two types of culture medium (BHI agar and TSA) in 
Mutacin typing of S. mutans detected distinct production 
patterns for the same strain. Through these observations, the 
author suggested that more than one type of mutacins could be 
synthesized by the same strain of S. mutans. Differences in the 
dimensions of the inhibition zones can also be attributed to the 
rate of diffusion of the substance in the culture medium and the 
mutacin concentration in agar (46). 
 Most strains of S. mutans produce mutacins in solid 
media, and previous studies have demonstrated that the 
inhibition zones observed on agar are not associated 
 1251 
Kamiya, R.U. et al.                    Mutacins of Streptococcus mutans 
 
 
with the presence of bacteriophage or the production of acids 
(6, 46). 
Currently, Mutacin typing applied to the phenotypic 
classification of S. mutans has been shown to be limited. For 
Eijsink et al. (14), the use of culture supernatants instead of 
purified bacteriocins in tests of antagonism can create restricted 
results as to the bacteriocin activity of strains. The use of 
purified bacteriocins on comparative analysis between strains 
producing is essential, since a bacteriocin producing strain can 
synthesize more than one type of inhibitory peptide (14). 
Even with the limitations of the technique, the mutacin 
typing is still employed (60), mainly associated with molecular 
typing methods (16, 26) as well as in combination with studies 
on the ecology and microbial virulence factors (26, 28) and 
purification and characterization of new bacteriocins with 
future applications in biotechnology (40).  
 
CLASSIFICATION AND DIVERSITY OF MUTACINS 
 
Kelstrup & Gibbons (29) initially suggested that 
bacteriocins of streptococci could be distinguished and 
characterized based on the inhibitory spectrum of activity, the 
morphology of the inhibition zone and sensitivity to 
chloroform and various enzymes. Kelstrup & Funder-Nielsen 
(31) divided the bacteriocins from S. mutans into two groups 
according to their molecular weight and sensitivity to heat. The 
first group was inactivated with heating at 80
o
C for 20 min and 
possessed a molecular mass> 10,000 Da, the second group was 
composed of small molecules (<10,000 Da) and heat stable. 
But the spectrum of activity, sensitivity to ether, chloroform 
and the trypsin varied considerably within the same group.  
Years later, Hamada & Ooshima (19) based on 
physicochemical properties and sensitivity to different enzymes 
proposed the existence of at least two groups of mutacins, 
sensitive or resistant to the action of proteases and lipases. 
Through these results, and analyzing the diffusion capacity of 
mutacins in cellophane, the authors concluded that mutacins 
can be represented by a variety of proteins of low molecular 
weight or high molecular weight polypeptide associated or not 
with lipids and / or polysaccharides. 
Subsequently, Caufield et al. (10) classified mutacin 
producing S. mutans in two groups, based on the spectrum of 
inhibition and cross-immunity. They also found that strains of 
group II produced mutacin type II in a liquid medium (TSB 
supplemented with 2% yeast extract), different strains of group 
I, mutacin type I producing. 
Through the techniques of purification and sequencing,  
mutacin I (48) and mutacin II (45), previously identified by 
Caufield et al. (10), were classified as lantibiotics (class of 
bacteriocins with residues of methyl-lantionine or β-methyl-
lantionine). Subsequently, Qi et al. (47) identified another 
lantibiotic, called mutacin III and reported the existence of a 
single strain of S. mutans (UA140) able to synthesize mutacins 
I (lantibiotic) and mutacins IV (non-lantibiotic) (49). Protein 
purification and sequencing has led to the identification 
characterization of other antimicrobial substances. In particular, 
the mutacin produced by S. mutans strain Ny266 (39) differs by 
two amino acids from those mutacin of strains S. mutans 
JH1140 (23) and S. mutans UA787 (mutacin III) (47).  
Morency et al. (38) showed phenotypically the diversity 
of antimicrobial peptides classifying 86 mutacinogenic strains 
in 24 different groups (A - X) based on similarity of their 
spectrum inhibition against 12 oral streptococci and cross-
immunity to other mutacin producing strains.  
In 2002, Ali et al. (2) compared the phenotypic grouping 
by activity spectra, previously described by Morency et al. 
(38), with genotypic analysis based on the sequences of genes 
encoding for mutacins pro-peptides. The amino acid sequences 
of four characterized mutacins (B-Ny266/1140/mutacin III and 
mutacin II) were used to design two DNA probes in order to 
detect similar genes among 24 phenotypic groups from A to X 
described previously by Morency et al. (38). The first probe 
was based on highly-conserved amino acid sequence of lanA 
from S. mutans Ny266, JH 1140 and UA787 (mutacin III) and 
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the second probe was selected from the sequence of mutA 
coding mutacin II produced by S. mutans T8 strain. Only six 
out in 24 S. mutans strains tested have genes that are similar to 
known lantibiotic sequences, indicating a rich diversity in 
bacteriocins that can be explored. In addition, strains with 
similar structural genes presented distinct phenotypic profiles. 
The difference in the pattern of production of antimicrobial 
substances, due in part to differential diffusion of substances in 
the culture medium (13), for example Nisin A and its 
homologous bacteriocin Nisin Z, produced by Lactococcus 
lactis, differ in one amino acid, but the spectrum of activity 
have only 83% similarity (11).    
The difficulty in classifying mutacins through its spectrum 
of activity or immunity is partly due to the use of culture 
supernatants in bacteriocin typing instead of substances 
previously purified. Restricted and contrasting results can be 
obtained, hindering comparative analysis of mutacins 
synthesis, since a single strain can produce more than one type 
of inhibitory substance (14).  
Currently, the characterization of phenotypic properties of 
mutacins is associated with genetic characterization, which 
includes sequencing, identification or screening of genes 
related to the biosynthesis of these substances in producing 
strains. Studies have detected a low frequency of biosynthesis 
genes of characterized mutacins in different 
phenotypes/genotypes of S. mutans confirming the existence of 
high diversity of these inhibitory substances, not yet identified, 
in the cariogenic species (27, 28). 
The chromosomal locations of structural genes of 
characterized mutacins I, II and III (47, 48) were confirmed by 
cloning and sequencing. Subsequently, Qi et al. (49) reported 
that the two components of mutacins IV, produced by the strain 
S. mutans UA140, are encoded by genes and nlmA and nmlB, 
also located in chromosomal DNA. 
Bacteriocins are synthesized by ribosomes as precursor 
peptides with a signal peptide at the N-terminus, typical of 
secreted proteins (42), which is cleaved concomitantly with the 
export of the mature peptide across the membrane (21). 
The bacteriocins synthesized by several species of bacteria 
have very different structures and activities, however, they 
preserve properties in common with each other. Generally, 
these proteins consist of 20-60 amino acid residues with 
positive electric charges and can be hydrophobic and / or 
amphiphilic, acting in the formation of pores in cell membranes 
or by reducing the metabolism of sensitive bacteria (43). 
In recent years, the antibacterial peptides, particularly 
synthesized by species of lactic acid bacteria (LAB) have 
attracted considerable interest in different areas of knowledge, 
and numerous bacteriocins of LAB have been characterized for 
probiotic purposes or for future use in therapy antibiotics 
against bacteria resistant to antibiotics currently used (40). 
Based on post-translational modification, the bacteriocins 
of Gram-positive were classified into two groups: class I 
bacteriocins modified after translation or lantibiotics and class 
II bacteriocins unmodified lantibiotics or not. The lantibiotics 
are small peptides containing lantionina, β-methyl-lantionina 
dehidratados residues and are synthesized by ribosomes and are 
modified after translation (55). Among mutacins well 
characterized, mutacins I, II, III, 1140, B-Ny 266, and SmbA 
SmbB are classified as lantibiotics (39, 47, 48, 62). The 
mutacin type IV (consisting of two peptides of synergistic 
activities, and NlmA NlmB) and N were classified as non 
lantibiotics (4, 49).  
Currently, fragments were sequenced open reading 
(ORFs) flanking the structural genes of mutacins IV, N, and 
SmbA SmbB and that is possibly related to regulation of the 
expression and production of their compounds (17, 18, 62) 
(Figure 1). The proximity of the structural genes of mutacins 
(mutN) and the signal peptide of competence (comC) suggests 
a correlation between the production of N mutacins and 
development of competence (17).  
The analysis of Figure 1 shows that the same strain of S. 
mutans is able to synthesize more than one type of antibacterial 
peptides. The strain S. mutans UA140 yielded three fractions 
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with inhibitory activity after chromatographic tests, then a fraction 
was identified as mutacins type I (a lantibiotic), and other fractions 
were corresponding to peptides non lantibiotics (NlmA and NlmB) 
of mutacins type IV (49). It has been identified in the strain S. 
mutans GS5, the presence and expression of structural genes of 
two peptide lantibiotics with synergistic activities (SmbA and 
SmbB) (62). In our studies, through screening by PCR and 
expression analysis of structural genes of characterized mutacins, 
it was possible to identify an isolate of S. mutans able to produce 
mutacins types I and II, both broad-spectrum inhibitory (28). 
 
 
 
Figure 1. Organization of clusters of genes involved in biosynthesis of characterized mutacins from Streptococcus mutans. Genes 
with similar functions have the same color (green encoding regulation protein of the production, blue encoding the pro-peptide, 
red encoding modification proteins, white related with transport and processing, yellow encoding immunity proteins, and pink 
represents an additional gene - mutD).* Sequencing cluster biosynthesis mutacins N, involves an ORF homologous to the 
transposase gene blpI and to the bacteriocin structural gene of Streptococcus pneumoniae. (Figure based on 4, 17, 47, 48, 49, 62). 
 
 
Robson et al. (51) identified the mutacin K8, a type AII 
lantibiotic produced by S. mutans K8 strain. The mutacin K8-
encoding muk locus consists of 13 ORFs, three of which 
(mukA1, A2 and A3) have close homology to scnA, the 
structural gene encoding the Streptococcus pyogenes lantibiotic 
SA-FF22, and another (mukA’) resembles scnA’, an ORF in 
the SA-FF22 locus that has no currently assigned function. The 
muk locus may be widely distributed in S. mutans, since 9 (35 
%) out of 26 strains tested contained at least part of the locus, 
although positive genes expression was not analyzed in this 
work. In the genome sequence of strain UA159 the muk locus 
is incomplete, the sole residual components being the ORFs 
encoding the putative two-component regulatory system mukR 
(SMU.1815) and mukK (SMU.1814), followed by two 
transposases (SMU.1813 and SMU.1812) and then the ORFs 
mukF (SMU.1811), mukE (SMU.1810) and mukG 
(SMU.1809), thought to encode putative immunity peptides. 
Strains such as UA159 having incomplete loci did not produce 
 1254 
Kamiya, R.U. et al.                    Mutacins of Streptococcus mutans 
 
 
detectable levels of mutacin K8. 
Previous studies had suggested the existence of a high 
diversity of mutacins produced by S. mutans which have not been 
identified yet (27, 28). Analysis of the S. mutans genome sequence 
(1) revealed 10 small open reading frames with high similarity to 
the leader peptides of NlmA and NlmB that encode class IIb 
bacteriocins (nonlantibiotics), each possessing a double-glycine-
type leader sequence similar to that of NlmAB (Figure 2) (18, 59). 
The putative bacteriocins, designed Bsm (bacteriocin 
Streptococcus mutans) ranged in size from 47 to 87 amino acids, 
had leader peptides from 22 to 25 amino acids, and contained a 
double glycine motif that could be recognized by the ComAB 
processing and export system (NlmTE), the same used for mutacin 
IV exportation. Some of the genes encoding the putative 
bacteriocins were located in tandem, indicating that they might act 
cooperatively, as it is typical for class IIb bacteriocins and these 
peptides would represent a large repertoire of antimicrobial 
substances produced by S. mutans (18, 59). 
Kamiya et al. (28) detected the frequency and expression of 
mutacins biosynthesis genes in isolates of S. mutans with different 
mutacin producing phenotypes. Detection of frequency and 
expression of genes encoding mutacins types I, II, III, and IV were 
performed by PCR and semi-quantitative RT-PCR, respectively, 
using specific primers for each type of biosynthesis genes. In 
addition, 8 more genes, encoding putative bacteriocins, designated 
Bsm 283, 299, 423, 1889c, 1892c, 1896, 1906c and 1914 were 
also screened. The frequency of the Bsm gene expression was 
higher than that of characterized mutacins (I to IV). In conclusion, 
the high diversity of producing phenotypes associated with the 
high frequency of screened Bsm biosynthesis genes expression 
reveal a broad repertoire of genetic determinants encoding 
antimicrobials peptides which can act in different combinations.  
 
 
NlmA MDTQAFEQFDVMDSQTLSTVEGG  
Bsm_283        MDTMAFENFDEIDMNHLASIEGG FDVKG 
Bsm_299       MNTKMMEQFETMDAETLSHVTGG GLYDG 
Bsm_423       MNTQAFEQFNVMDNEALSTVEGG GMIRC      
Bsm 1889c      MMNTRTLEQFDAMDVDMLAAVEGG NWGQC 
Bsm_1892c     MKTQTEIWKRFEALDTADLAIIQGG SENIA 
Bsm_1896      MMEIKALDQFETMDTDMLAAVEGG FGWDS 
Bsm_1906       MNTHVLEQFDVMDSQVPSAIEGG GCSWK 
Bsm_1914c       MNTQAFEQFNVMDNEALSAVEGG GRGWN 
NlmB        MELNVNNYKSLTNDELSEVFGG SGSLS 
Figure 2. Clustal W sequence alignment of NlmA and NlmB (two preptides of mutacin IV) with other prepeptides sequences 
identified in S. mutans UA159 genome. These prepeptides contain the double-glycine motif. Adapted from van DER PLOEG (59) 
and Hale et al. (18). 
 
 
REGULATORY MECHANISMS RELATED WITH 
MUTACIN PRODUCTION 
 
The production of bacteriocins by Gram-positive bacteria 
is generally associated with the transition from log phase to 
stationary phase of bacterial growth (8) or the cell density in 
the culture medium (50). Such statements may suggest intense 
bacteriocin activity in dental biofilm, where there is high cell 
density and complexity. 
There is evidence that the mutacins can play an important 
role in the protection and colonization of S. mutans in the oral 
cavity, especially in complex environments, such as dental 
biofilm and caries (4). The synthesis of broad-spectrum 
antimicrobial peptides was observed in genotypes of S. mutans 
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isolated from caries-active individuals, who have a resident 
microbiota more diverse and complex in relation to caries-free 
individuals (26). The production of these substances in vivo 
suggests ecological advantages to the producer strain by 
replacing the resident microbiota and prevention of invasion by 
exogenous microorganisms (22). 
In addition, in vitro studies suggested greater biological 
activity of mutacins characterized in dental biofilm than in 
saliva, due to increased production of inhibitory substances by 
sessile colonies grown on solid media compared to planktonic 
cells, grown in liquid media (34). The patterns of gene 
expression and consequently phenotypes developed in 
planktonic and biofilm state are different, probably due to 
environmental differences which bacterial cells are exposed to 
(9). 
Furthermore, some studies have linked the production of 
antimicrobial peptides with the Quorum Sensing System, 
demonstrating the increased expression of structural genes 
under conditions of greater cell density and control gene 
expression through regulatory mechanisms pertaining to this 
system (17, 49, 59, 62).  
Conditions in the biofilm, such as high cell density and 
increased environmental stress, among other factors activate 
the quorum sensing system by increasing the concentration of 
peptide pheromones or signals that coordinate protective 
functions and cell survival, which include cellular mechanisms 
of competence, resistance to acid pH and production of 
mutacins (59). 
Basically, the quorum sensing system via signal 
transduction is accomplished via two regulatory components 
consisting of a histidine protein kinase, associated with the 
cytoplasmic membrane, and a second regulatory protein, 
located in the cytoplasm. The histidine protein kinase captures 
the presence of peptide signals in the environment and 
transmits this signal through the phosphorylation of regulatory 
protein which activates transcription of target genes involved in 
adaptation, survival and virulence mechanisms (59). This 
system functions as a modulator of expression of different 
genes in response to environmental changes.  
The genome of Streptococcus mutans harbors 13 two-
component signal transduction systems (TCSTSs). Many of 
these two-component systems are well known to regulate 
several virulence-associated traits in vitro experiments, 
including genetic competence, bacteriocin production, biofilm 
formation, acid tolerance and stress responses. 
Among mutacins well characterized, genes expressions of 
mutacins I, IV and Smb are controlled by the increase in cell 
density (in vitro) (59, 62). In addition, it was shown that 
protein kinases CiaH, ComD and LiaS components are 
important regulators that coordinate the expression of genes for 
production of these mutacins (59, 62). These regulatory 
mechanisms support an important means of signaling the 
expression of virulence factors related to the survival of 
producing strains especially in complex and competitive 
environments as the dental biofilm and caries. 
Mutacin production is controlled by many genetic as well 
as environmental factors. While the non-lantibiotic mutacin IV 
is controlled by quorum sensing via the three-component 
system comCDE, associated with cell competence mechanism 
(34, 35), regulation of the lantibiotic mutacin I is much more 
complex and less understood. 
Previous studies indicate that the proteins encoded by 
ciaH and luxS are required for mutacin I production (37). LuxS 
is responsible for the synthesis of the interspecies cell signaling 
molecule autoinducer 2 (AI-2) (56). In addition to regulating 
mutacin I production, both CiaH and LuxS were also found to 
be involved in regulating other cellular functions in S. mutans 
such as biofilm formation and stress tolerance (36). 
Tsang et al. (57) used a random insertional mutagenesis 
approach to search for genes that are associated with mutacin I 
production in the virulent strain UA140. A random insertional 
mutagenesis library consisting of 11 000 clones was 
constructed and screened for a mutacin-defective phenotype. 
Mutacin-defective clones were isolated, and their insertion sites 
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were determined by PCR amplification or plasmid rescue 
followed by sequencing. A total of twenty-five unique genes 
were identified. These genes can be categorized into the 
following functional classes: two-component sensory systems, 
stress responses, energy metabolism and central cellular 
processes. Several conserved hypothetical proteins with 
unknown functions were also identified. These results suggest 
that mutacin I production is stringently controlled by diverse 
and complex regulatory pathways. 
In a previous study, Tsang at al. (57) constructed a 
random insertional-mutation library to screen for genes 
involved in regulating mutacin I production, and found 25 
genes/operons that have a positive effect on mutacin I 
production. Later, Nguyen et al. (44) identified 17 genes whose 
mutation increased mutacin I production under repressive 
conditions. These genes are involved in a variety of cellular 
functions such as sugar transport, protein/peptide hydrolysis, 
amino acid and nucleotide synthesis, cell-wall metabolism, 
surface binding and unknown functions. These results further 
demonstrate an intimate and intricate connection between 
mutacin I production and the overall cellular homeostasis.  
The regulatory mechanisms involved in mutacins 
production, as well as cell density, quorum sensing and the 
interspecies signaling system mediated by autoinducer 
molecules suggest that producing strains can benefit in 
environments with highly complex microbial population, such 
as dental biofilm and caries. In an environment such as the 
dental biofilm, energy expenditures may be better utilized by 
producing bacteriocins when the total population density is 
high and competitors are likely to be present. This may be 
particularly true for mutacins production, which requires many 
gene products to make a mature peptide. 
 
CONCLUDING REMARKS 
 
In conclusion, there is great diversity of mutacins 
unexplored. Many studies showed that these antimicrobial 
substances may promote the transmissibility of cariogenic 
species, as well as colonization and stability of S. mutans in the 
oral cavity. In addition, the regulatory mechanisms involved in 
increased mutacins production, as well as high cell density, 
quorum sensing and signaling system of auto-inducer 
molecules suggest that producing strains can have ecologic 
advantages in environments with highly complex microbial 
population, such as dental biofilm and caries. 
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